Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-01-07 5:18 pm Unchanged | 13D | BEIGENE LTD SPONSORED ADR BGNE | BAKER BROS. ADVISORS LP | 159,118,860 15.8% | 0 (Unchanged) | View |
| 2019-12-20 5:17 pm Sale | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 3,805,000 9.99% | -7,502,939 (-66.35%) | View |
| 2019-12-06 4:45 pm Purchase | 13D | KODIAK SCIENCES INC KOD | BAKER BROS. ADVISORS LP | 11,197,288 25.4% | 1,902,173 (+20.46%) | View |
| 2019-11-18 5:16 pm Sale | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 11,307,939 29.5% | -54,000 (-0.48%) | View |
| 2019-11-06 5:18 pm Purchase | 13D | BEIGENE LTD SPONSORED ADR BGNE | BAKER BROS. ADVISORS LP | 159,118,860 20.3% | 3,415,472 (+2.19%) | View |
| 2019-10-11 4:21 pm Purchase | 13D | DBV TECHNOLOGIES S.A. AMERICAN DBVT | BAKER BROS. ADVISORS LP | 11,164,669 23.7% | 4,552,351 (+68.85%) | View |
| 2019-10-04 4:23 pm Sale | 13D | MIRATI THERAPEUTICS INC MRTX | BAKER BROS. ADVISORS LP | 1,995,200 4.99% | -1,593,648 (-44.41%) | View |
| 2019-09-20 4:51 pm Purchase | 13D | IGM BIOSCIENCES INC IGMS | BAKER BROS. ADVISORS LP | 3,144,000 13% | 3,144,000 (New Position) | View |
| 2019-09-20 4:48 pm Purchase | 13D | ACADIA PHARMACEUTICALS INC ACAD | BAKER BROS. ADVISORS LP | 41,167,857 27.1% | 1,243,368 (+3.11%) | View |
| 2019-09-06 5:15 pm Sale | 13G | IDERA PHARMACEUTICALS, INC IDRA | BAKER BROS. ADVISORS LP | 4,696,102 16.3% | -202,745 (-4.14%) | View |
| 2019-08-22 4:09 pm Unchanged | 13D | BELLICUM PHARMACEUTICALS INC C BLCM | BAKER BROS. ADVISORS LP | 2,677,818 5.8% | 0 (Unchanged) | View |
| 2019-08-13 5:08 pm Purchase | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 11,361,939 40.3% | 11,361,939 (New Position) | View |
| 2019-08-07 5:28 pm Purchase | 13D | AQUINOX PHARMACEUTICALS INC AQXP | BAKER BROS. ADVISORS LP | 11,361,939 48.2% | 425,525 (+3.89%) | View |
| 2019-07-31 5:24 pm Purchase | 13D | GENOMIC HEALTH INC GHDX | BAKER BROS. ADVISORS LP | 9,596,023 25.8% | 424 (+0.00%) | View |
| 2019-07-30 5:23 pm Purchase | 13D | MIRATI THERAPEUTICS INC MRTX | BAKER BROS. ADVISORS LP | 3,588,848 8.7% | 875,864 (+32.28%) | View |
| 2019-06-07 5:20 pm Sale | 13D | KINIKSA PHARMACEUTICALS LTD KNSA | BAKER BROS. ADVISORS LP | 2,865,509 15% | -165,759 (-5.47%) | View |
| 2019-06-07 5:13 pm Sale | 13D | INCYTE CORPORATION INCY | BAKER BROS. ADVISORS LP | 32,551,585 15.2% | -1,969,591 (-5.71%) | View |
| 2019-06-06 5:13 pm Purchase | 13D | IDERA PHARMACEUTICALS, INC IDRA | BAKER BROS. ADVISORS LP | 4,898,847 17.4% | 10,888 (+0.22%) | View |